Krka DD (LTS:0HLK) Inventories, Work In Process: €131 Mil (As of Mar. 2026)


LTS:0HLK Krka DD LTS:0HLK
84 GF Score
Price €64.80
GF Value €41.99
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Krka DD Inventories, Work In Process?

Krka DD LTS:0HLK 84 Inventories, Work In Process is €131 Mil as of Mar. 2026. GuruFocus rates LTS:0HLK with a GF Score™ of 84/100 and a GF Value™ of €41.99 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Krka DD's work in process for the quarter that ended in Mar. 2026 was €131 Mil.

Krka DD Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Krka DD's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krka DD Inventories, Work In Process Chart

Krka DD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 104.64 125.93 128.61 121.52 122.08

Krka DD Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 129.56 123.33 118.04 122.08 131.49
LTS:0HLK
84GF Score
Krka DD LTS:0HLK
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krka DD Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of €131 Mil mean?
Krka DD (LTS:0HLK) has a Inventories, Work In Process of €131 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Krka DD and its competitors.
Is Krka DD's Inventories, Work In Process too high?
Krka DD's current Inventories, Work In Process is €131 Mil. Overall, Krka DD has a GF Score™ of 84/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krka DD's Inventories, Work In Process compare to ZTS and UTHR?
Krka DD's Inventories, Work In Process of €131 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Krka DD and its competitors. Krka DD's current Inventories, Work In Process is €131 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krka DD stock overvalued right now?
Based on GuruFocus' analysis, Krka DD (LTS:0HLK) is currently considered Significantly Overvalued. The stock's GF Value™ is €41.99, compared to a current price of €64.80 — trading 54.3% above its estimated fair value. The current Inventories, Work In Process is €131 Mil. Krka DD's overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Krka DD (LTS:0HLK), the current Inventories, Work In Process is €131 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krka DD (LTS:0HLK) Overvalued in 2026?

Based on GuruFocus' analysis, Krka DD stock appears to be overvalued. The current stock price of €64.80 is trading 54.3% above its estimated GF Value™ of €41.99. GuruFocus considers Krka DD to be Significantly Overvalued.

Key valuation signals for LTS:0HLK:

  • Inventories, Work In Process: €131 Mil
  • GF Value™: €41.99 vs. price of €64.80 (54.3% above fair value)
  • GF Score™: 84/100 with 6 warning signs

No single metric tells the full story. See the LTS:0HLK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krka DD Business Description

Address Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company's products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, Eastern Europe region, and Others. The company derives a majority of its revenue from the European Union.
84GF Score

Get the complete analysis for LTS:0HLK

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€64.80
Price
€41.99
GF Value